Opinion
Video
The Impact of MRI-Guided Biopsy in Diagnosis and Treatment Decisions
Author(s):
Kyrollis Attalla, MD, shares his approach to imaging and biopsy in the diagnosis of prostate cancer and discusses the benefit of a good biopsy followed by appropriate imaging at initial diagnosis.
Video Player is loading.
Video content above is prompted by the following questions:
- Can you please share your approach to imaging and biopsy in the diagnosis of prostate cancer?
- What is the role of a good biopsy followed by the right imaging when a patient is first diagnosed with prostate cancer?
- How can these aid in guiding treatment decisions and ensuring best outcomes for patients?
Related Videos
Strategies to bridge gender disparities in AAS and citations in the oncology literature
Stacy Loeb, MD, MSc, PhD (Hon), discusses the nuances of prostate cancer screening
Selecting Between Receptor Pathway Inhibitors for mHSPC
The Use of Ultra-Low PSA in Specific Patient Profiles
Fred Saad, MD, FRCS, discusses clinical impact of darolutamide approval in mCSPC
Ryan Hankins, MD, on rectal spacer utilization and erectile dysfunction
Adam Weiner, MD, on therapeutic decision-making in metastatic prostate cancer
Fred Saad, MD, FRCS, reacts to FDA approval of darolutamide in mCSPC
Using Ultrasensitive PSA Assays in Routine Practice
Ultra-Low PSA Response as a Trial End Point or Clinical Decision Point
Related Content
